Onyx Pharmaceuticals, Inc.
Records under this name other than the patents Onyx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Onyx Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,809,526 | Synthesis of cyclopentaquinazolines Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,458,188 | Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline trisodium salt Formerly held In force · USPTO record | In force | USPTO record | |
| US 6,500,653 | Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins Term ended Term ended Aug 9, 2019 · USPTO record | Term ended | Term ended Aug 9, 2019 | USPTO record |
| US 6,428,960 | Selection method for producing recombinant baculovirus Term ended Term ended Mar 4, 2019 · USPTO record | Term ended | Term ended Mar 4, 2019 | USPTO record |
| US 6,017,763 | G-beta-gamma regulated phosphatidylinositol-3' kinase Term ended Term ended Jan 4, 2019 · USPTO record | Term ended | Term ended Jan 4, 2019 | USPTO record |
| US 7,785,887 | Adenovirus E1B-55K Single Amino Acid Mutants and Methods of Use Lapsed on the fee record Ended Aug 31, 2018 · Medium confidence | Lapsed on the fee record | Ended Aug 31, 2018 | Medium confidence |
| US 6,048,706 | Human PAK65 Term ended Term ended Jul 1, 2018 · USPTO record | Term ended | Term ended Jul 1, 2018 | USPTO record |
| US 6,187,799 | Inhibition of raf kinase activity using aryl ureas Formerly held Term ended Term ended May 22, 2018 · USPTO record | Term ended | Term ended May 22, 2018 | USPTO record |
| US 6,340,575 | Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity Term ended Term ended May 15, 2018 · USPTO record | Term ended | Term ended May 15, 2018 | USPTO record |
| US 6,133,419 | Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof Term ended Term ended Oct 1, 2017 · USPTO record | Term ended | Term ended Oct 1, 2017 | USPTO record |